Cargando…

Effects of palliative radiotherapy and bisphosphonate usage on bone turnover marker levels in cancer patients with osteolytic bone metastases

OBJECTIVES: In this study, we aimed to investigate the bone turnover marker levels according to bisphosphonate usage and radiotherapy (RT) in cancer patients with metastases in osteolytic pattern. PATIENTS AND METHODS: A total of 52 patients (13 males, 39 females; median age: 52 years; range, 37 to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Göksel, Fatih, Akmansu, Müge, Şentürk, Ertuğrul, Demircioğlu, Fatih
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bayçınar Medical Publishing 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8650665/ https://www.ncbi.nlm.nih.gov/pubmed/34842103 http://dx.doi.org/10.52312/jdrs.2021.76037

Ejemplares similares

Bisphosphonate Treatment of Benign Multifocal and Unifocal Osteolytic Tumours of Bone
por: Gibbons, C. L. M. H., et al.
Publicado: (2003)

Ra223 in Bone Metastases with Osteolytic Activity
por: Costa, Renato Patrizio, et al.
Publicado: (2018)

Bisphosphonates and bone metastases.
por: Morton, A. R., et al.
Publicado: (1988)

Effects of de-escalated bisphosphonate therapy on bone turnover biomarkers in breast cancer patients with bone metastases
por: Addison, Christina L, et al.
Publicado: (2014)

Stability and survival analysis of elderly patients with osteolytic spinal bone metastases after palliative radiotherapy: Results from a large multicenter cohort
por: Bostel, Tilman, et al.
Publicado: (2019)

Effects of a 'Drug Holiday' on Bone Mineral Density and Bone Turnover Marker During Bisphosphonate Therapy
por: Kong, Sung Yeol, et al.
Publicado: (2013)

Significant improvement of bone mineral density and bone turnover markers by denosumab therapy in bisphosphonate-unresponsive patients
por: Kamimura, M., et al.
Publicado: (2016)

Bone Microenvironment‐Suppressed T Cells Increase Osteoclast Formation and Osteolytic Bone Metastases in Mice
por: Arellano, Danna L., et al.
Publicado: (2022)

Can bone turnover markers help to define the suitability and duration of bisphosphonate drug holidays?
por: Statham, Louise, et al.
Publicado: (2020)

Effects of denosumab on bone mineral density and bone turnover markers in rheumatoid arthritis patients switching from bisphosphonates
por: Kaneko, Tetsuya, et al.
Publicado: (2019)

Markers of bone turnover for the management of patients with bone metastases from prostate cancer
por: Garnero, P, et al.
Publicado: (2000)

Association between Bone Mineral Density and Bone Turnover Markers in Breast Cancer Patients and Bone-Only Metastasis
por: Kundaktepe, Berrin Papila, et al.
Publicado: (2021)

Suppression of NADPH Oxidase Activity May Slow the Expansion of Osteolytic Bone Metastases
por: McCarty, Mark F., et al.
Publicado: (2016)

Use of palliative radiotherapy in brain and bone metastases (VARA II study)
por: Expósito, Jose, et al.
Publicado: (2012)

Comparison of Single Versus Multifraction Radiotherapy in Palliation of Painful Bone Metastases
por: Nongkynrih, Anthialisha, et al.
Publicado: (2018)

Quality of life improvement in patients with bone metastases undergoing palliative radiotherapy
por: Cañón, Verónica, et al.
Publicado: (2022)

Radiation therapy combined with bone-modifying agents ameliorates local control of osteolytic bone metastases in breast cancer
por: Tanaka, Hidekazu, et al.
Publicado: (2020)

Vascular endothelial growth factor acts as an osteolytic factor in breast cancer metastases to bone
por: Aldridge, S E, et al.
Publicado: (2005)

Atypical presentation of colorectal carcinoma with sole multiple osteolytic bone metastases: acase report
por: Kawamura, Ren, et al.
Publicado: (2021)

Biochemical markers of bone turnover in patients with spinal metastases after resistance training under radiotherapy – a randomized trial
por: Rief, Harald, et al.
Publicado: (2016)

Bone turnover is adequately suppressed in osteoporotic patients treated with bisphosphonates in daily practice
por: Eekman, Danielle A, et al.
Publicado: (2011)

Circulating markers of bone turnover
por: Vervloet, Marc G., et al.
Publicado: (2017)

Quality of life after palliative radiotherapy in bone metastases: A literature review
por: McDonald, Rachel, et al.
Publicado: (2014)

Evaluation of effectiveness of palliative radiotherapy for bone metastases: a prospective cohort study
por: van der Velden, Joanne M., et al.
Publicado: (2018)

Optimizing Clinical Benefits of Bisphosphonates in Cancer Patients with Bone Metastases
por: Aapro, Matti, et al.
Publicado: (2010)

Novel Radiolabeled Bisphosphonates for PET Diagnosis and Endoradiotherapy of Bone Metastases
por: Pfannkuchen, Nina, et al.
Publicado: (2017)

TIE2 Induces Breast Cancer Cell Dormancy and Inhibits the Development of Osteolytic Bone Metastases
por: Drescher, Florian, et al.
Publicado: (2020)

Effect of glycosphingolipids on osteoclastogenesis and osteolytic bone diseases
por: Ersek, Adel, et al.
Publicado: (2012)

Implanted bisphosphonates in bone cement affect bone markers in rat serum
por: Mazurkiewicz, Tomasz, et al.
Publicado: (2013)

Changes in bone turnover markers in patients without bone metastases receiving immune checkpoint inhibitors: An exploratory analysis
por: Pantano, Francesco, et al.
Publicado: (2022)

Prognostic Impact of the Tumor Marker CA 15-3 in Patients With Breast Cancer and Bone Metastases Treated With Palliative Radiotherapy
por: Nieder, Carsten, et al.
Publicado: (2017)

Evidence-based guidelines for the use of biochemical markers of bone turnover in the selection and monitoring of bisphosphonate treatment in osteoporosis: a consensus document of the Belgian Bone Club
por: Bergmann, P, et al.
Publicado: (2009)

Bisphosphonates Preserve Bone Mineral Density and Suppress Bone Turnover Markers in Early Menopausal Women: A Systematic Review and Meta‐Analysis of Randomized Trials
por: Ahadzadeh Ardebili, Aria, et al.
Publicado: (2023)

Arachnoid Granulations Mimicking Multiple Osteolytic Bone Lesions in the Occipital Bone
por: Park, Seong-Hyun, et al.
Publicado: (2018)

Radiotherapy fractionation for the palliation of uncomplicated painful bone metastases – an evidence-based practice guideline
por: Wu, Jackson Sai-Yiu, et al.
Publicado: (2004)

Survival and Stability of Patients with Urothelial Cancer and Spinal Bone Metastases after Palliative Radiotherapy
por: Foerster, Robert, et al.
Publicado: (2017)

Bisphosphonates in oncology: evidence for the prevention of skeletal events in patients with bone metastases
por: Polascik, Thomas J
Publicado: (2009)

Analysis of the Mechanism and Safety of Bisphosphonates in Patients with Lung Cancer and Bone Metastases
por: Zhang, Gao, et al.
Publicado: (2021)

Role of Tumor-Derived Chemokines in Osteolytic Bone Metastasis
por: Coniglio, Salvatore J.
Publicado: (2018)

Osteocyte CIITA aggravates osteolytic bone lesions in myeloma
por: Liu, Huan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5p3uvhtk9npkbqgtqegqqbm9n6